Fredrick B Hagemeister Selected Research

Fredrick B Hagemeister Research Topics

Disease

24	Lymphoma (Lymphomas) 01/2021 - 05/2002
14	Neoplasms (Cancer) 01/2022 - 03/2002
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2015 - 06/2003
11	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 12/2002
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2022 - 12/2013
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 04/2006
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022 - 07/2010
4	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 02/2003
4	Disease Progression 06/2014 - 05/2002
3	Neutropenia 01/2018 - 07/2005
2	Cytopenia 10/2021 - 05/2012
2	Opportunistic Infections (Opportunistic Infection) 10/2021 - 07/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 11/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 06/2005
2	Thrombocytopenia (Thrombopenia) 01/2018 - 11/2015
1	Long Term Adverse Effects 10/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	cell-associated neurotoxicity 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019
1	Serositis 01/2019
1	Plasmablastic Lymphoma 03/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2015
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2015
1	Radiation Pneumonitis 05/2015
1	Cardiotoxicity 03/2015
1	Metabolic Bone Diseases (Osteopenia) 04/2013
1	Venous Thromboembolism 10/2010

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 10/2022 - 02/2003
8	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2003
6	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 01/2003
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2003
6	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2010
6	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2021 - 12/2002
6	fludarabineIBA 01/2021 - 12/2002
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 07/2010
4	Prednisone (Sone)FDA LinkGeneric 03/2015 - 01/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 05/2002
3	ibrutinibIBA 10/2022 - 01/2019
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
3	InterferonsIBA 01/2017 - 07/2005
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2014 - 05/2002
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 06/2005
2	Biological ProductsIBA 01/2022 - 04/2006
2	axicabtagene ciloleucelIBA 10/2021 - 01/2020
2	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2005
2	Ifosfamide FDA LinkGeneric 01/2018 - 05/2002
2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 05/2002
2	IceIBA 01/2018 - 05/2002
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 03/2015
2	N 30IBA 11/2014 - 03/2002
2	Alkylating AgentsIBA 04/2013 - 02/2004
2	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012 - 01/2003
2	denileukin diftitox (Ontak)FDA Link 02/2007 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 02/2007 - 10/2004
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Vorinostat FDA Link 11/2020
1	Histone Deacetylase InhibitorsIBA 11/2020
1	Everolimus FDA Link 11/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	MTOR InhibitorsIBA 11/2020
1	Sirolimus (Rapamycin)FDA Link 11/2020
1	MLN 8237IBA 01/2020
1	romidepsin (FK228)FDA Link 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	PanobinostatIBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2017
1	1-dodecylpyridoxal (PLD)IBA 03/2015
1	R-CHOP protocolIBA 03/2015
1	AnthracyclinesIBA 03/2015
1	Dihydrotachysterol (AT 10)IBA 11/2014
1	PlatinumIBA 10/2014
1	Vitamin D FDA LinkGeneric 04/2013
1	CalciumIBA 04/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2013
1	Zoledronic Acid (Zometa)FDA Link 04/2013
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012
1	Dacarbazine (DIC)FDA LinkGeneric 05/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012
1	CreatinineIBA 10/2010
1	Hemoglobins (Hemoglobin)IBA 10/2010

Therapy/Procedure

28	Therapeutics 11/2021 - 05/2002
21	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
10	Radiotherapy 12/2017 - 03/2002
2	Aftercare (After-Treatment) 07/2010 - 01/2003
2	Stem Cell Transplantation 07/2010 - 12/2002
2	Combined Modality Therapy 02/2004 - 06/2003
1	Transplantation 01/2021
1	Radioimmunotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 05/2015
1	Animal Assisted Therapy 06/2014
1	Drug Tapering 05/2012